{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:16:30Z","timestamp":1793661390842,"version":"4.5.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bmc.2020.115644","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:17:03Z","timestamp":1594959423000},"page":"115644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Identification of the first noncompetitive SARM1 inhibitors"],"prefix":"10.1016","volume":"28","author":[{"given":"Heather S.","family":"Loring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangram S.","family":"Parelkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2020.115644_b0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000110320","article-title":"Projected neurodegenerative disease mortality in the United States, 1990\u20132040","volume":"12","author":"Lilienfeld","year":"1993","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.bmc.2020.115644_b0010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(14)61347-7","article-title":"The burden of disease in older people and implications for health policy and practice","volume":"385","author":"Prince","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2020.115644_b0015","doi-asserted-by":"crossref","first-page":"778","DOI":"10.47102\/annals-acadmedsg.V32N6p778","article-title":"A palliative care approach to end-stage neurodegenerative conditions","volume":"32","author":"Low","year":"2003","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.bmc.2020.115644_b0020","article-title":"Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases","author":"Loring","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmc.2020.115644_b0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1460-9568.1989.tb00771.x","article-title":"Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve","volume":"1","author":"Lunn","year":"1989","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bmc.2020.115644_b0030","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.0.CO;2-8","article-title":"Traumatic brain injury causes delayed motor and cognitive impairment in a mutant mouse strain known to exhibit delayed Wallerian degeneration","volume":"53","author":"Fox","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bmc.2020.115644_b0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.10300","article-title":"WldS mice are resistant to paclitaxel (taxol) neuropathy","volume":"52","author":"Wang","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bmc.2020.115644_b0040","doi-asserted-by":"crossref","unstructured":"Osterloh, J. M., Yang, J., Rooney, T. M., Fox, A. N., Adalbert, R., Powell, E. H., Sheehan, A. E., Avery, M. A., Hackett, R., Logan, M. A., MacDonald, J. M., Ziegenfuss, J. S., Milde, S., Hou, Y. J., Nathan, C., Ding, A., Brown, R. H., Jr., Conforti, L., Coleman, M., Tessier-Lavigne, M., Zuchner, S., and Freeman, M. R. (2012) dSarm\/Sarm1 is required for activation of an injury-induced axon death pathway, Science 337, 481-484.","DOI":"10.1126\/science.1223899"},{"key":"10.1016\/j.bmc.2020.115644_b0045","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1523\/JNEUROSCI.1197-13.2013","article-title":"Sarm1-mediated axon degeneration requires both SAM and TIR interactions","volume":"33","author":"Gerdts","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2020.115644_b0050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1258366","article-title":"SARM1 activation triggers axon degeneration locally via NAD(+) destruction","volume":"348","author":"Gerdts","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bmc.2020.115644_b0055","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/brain\/aww001","article-title":"Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1","volume":"139","author":"Henninger","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.bmc.2020.115644_b0060","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1093\/brain\/aww251","article-title":"Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice","volume":"139","author":"Geisler","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.bmc.2020.115644_b0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exer.2018.03.007","article-title":"Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury","volume":"171","author":"Fernandes","year":"2018","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.bmc.2020.115644_b0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2012.01.014","article-title":"Intrinsic axonal degeneration pathways are critical for glaucomatous damage","volume":"246","author":"Howell","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bmc.2020.115644_b0075","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/acs.biochem.9b01078","article-title":"Initial Kinetic Characterization of Sterile Alpha and Toll\/Interleukin Receptor Motif-Containing Protein 1","volume":"59","author":"Loring","year":"2020","journal-title":"Biochemistry"},{"issue":"1334\u20131343","key":"10.1016\/j.bmc.2020.115644_b0080","article-title":"The SARM1 Toll\/Interleukin-1 Receptor Domain Possesses Intrinsic NAD(+) Cleavage Activity that Promotes Pathological Axonal Degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.bmc.2020.115644_b0085","first-page":"5","article-title":"NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD(+) depletion","author":"Sasaki","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.bmc.2020.115644_b0090","doi-asserted-by":"crossref","first-page":"10093","DOI":"10.1073\/pnas.1508337112","article-title":"Local axonal protection by WldS as revealed by conditional regulation of protein stability","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmc.2020.115644_b0095","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2174\/1568026615666150827095433","article-title":"The Role of Berberine in the Multi-Target Treatment of Senile Dementia","volume":"16","author":"Huang","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2020.115644_b0100","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.pharep.2015.03.002","article-title":"Berberine and neurodegeneration: A review of literature","volume":"67","author":"Ahmed","year":"2015","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bmc.2020.115644_b0105","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","article-title":"Berberine ameliorates beta-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model","volume":"33","author":"Durairajan","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bmc.2020.115644_b0110","doi-asserted-by":"crossref","first-page":"E6271","DOI":"10.1073\/pnas.1601506113","article-title":"SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation","volume":"113","author":"Summers","year":"2016","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620304740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620304740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:08:01Z","timestamp":1760836081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620304740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":22,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0968089620304740"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115644","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the first noncompetitive SARM1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115644"}}